title: Reactivity of pulmonary circulation and right ventricle function to inhaled nitric oxide in systemic sclerosis patients.
abstract: Systemic sclerosis (SSc) is complicated by pulmonary hypertension and right ventricle (RV) failure in approximately 10% of the patients. Factors influencing the reactivity of pulmonary circulation to vasodilators are not established, while the examination of vasoreactivity is important in determining the treatment, because systemic administration of oral vasodilators can induce severe adverse events in nonresponders. The mechanism of RV failure in SSc is unclear and may result either from increased RV afterload or intrinsic myocardial disease. The aim of the study was to assess the reactivity of pulmonary circulation to inhaled nitric oxide (iNO) and to evaluate its influence on RV function in SSc patients with elevated right ventricle systolic pressure (RVSP). In 60 SSc patients aged 24-73 (58 females, two males; 33 patients with limited SSc and 27 with diffuse SSc), echocardiographic examination with tissue Doppler echocardiography (TDE) was performed. RV function was measured by systolic (S) and early diastolic (E) velocity of tricuspid annulus by TDE. In patients with RVSP >45 mmHg, the reactivity of pulmonary circulation was assessed by iNO test. High-resolution computerized tomography (HRCT) was performed to assess the extent of pulmonary fibrosis. Of 14 SSc subjects with elevated RVSP (13 females, one male; RVSP 47-62 mmHg), positive reaction to iNO was observed in five (RVSP decreased from 51.6 ± 3.7 to 32.24 ± 2.3 mmHg); nine patients were not reactive (RVSP 53.5 ± 5.7 mmHg before iNO vs. 49.6 ± 6.7 mmHg). RV systolic function was decreased in patients with elevated RVSP as compared to the patients with normal pulmonary pressure (S velocity 13.2 ± 1.3 vs. 14.4 ± 1.6 cm/s, respectively, p < 0.05). Significant increase of RV systolic function during iNO test was found in reactive patients only (S velocity before iNO 12.8 ± 1.2 cm/s, during iNO 14.5 ± 1.5 cm/s, p < 0.01). RVSP decrease strongly correlated with S velocity increase (r = 0.95, p < 0.0001). Response to iNO was found only in limited form of SSc; diffuse SSc patients showed no response. Pulmonary fibrosis on HRCT was more frequent in subjects nonreactive to iNO (67% of patients) than in the reactive group (40% of patients). The reactivity of pulmonary circulation to iNO in SSc patients with elevated RVSP was found predominantly in limited form of the disease. Pulmonary fibrosis typical for diffuse SSc was more frequent in nonreactive subjects. Elevated pulmonary pressure plays an important role in RV systolic dysfunction. Pulmonary pressure decrease during iNO test leads to the improvement of RV systolic function. Therapy for right-heart failure in reactive SSc patients should be directed, if possible, at the decrease in pulmonary resistance.
authors.affiliation: Department of Cardiac and Vascular Diseases, John Paul II Hospital, Jagiellonian University Medical College, Pradnicka Str 80, 31-202 Krakow, Poland. wplazak@szpitaljp2.krakow.pl
authors.forename: Wojciech
authors.initials: W
authors.lastname: Plazak
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Gryga
authors.forename: Jan
authors.initials: J
authors.lastname: Sznajd
authors.forename: Joanna
authors.initials: J
authors.lastname: Wilisowska
authors.forename: Ewa
authors.initials: E
authors.lastname: Czarnobilska
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Goncerz
authors.forename: Piotr
authors.initials: P
authors.lastname: Podolec
authors.forename: Jacek
authors.initials: J
authors.lastname: Musial
mesh_terms: D000328:Adult; D000368:Aged; D015150:Echocardiography, Doppler; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D019570:Inhalation Exposure; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide; D011652:Pulmonary Circulation / Q000187:drug effects*; D045743:Scleroderma, Diffuse / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D045745:Scleroderma, Limited / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D014665:Vasodilator Agents; D016278:Ventricular Function, Right / Q000187:drug effects*; D055815:Young Adult
chemical_list: D014665:Vasodilator Agents; D009569:Nitric Oxide